1
David Haffner, Gregory T Smedley, Hosheng Tu: Devices and methods for treatment of ocular disorders. Glaukos Corporation, Knobbe Martens Olson & Bear, January 11, 2011: US07867186 (67 worldwide citation)

Intraocular implants and delivery instruments are disclosed for treating ophthalmic conditions and ocular disorders, such as glaucoma. The implants are configured to extend between the anterior chamber of the eye and a fluid outflow path or physiologic outflow pathway, such as Schlemm's canal, of th ...


2
David Haffner, Gregory T Smedley, Hosheng Tu: Devices and methods for treatment of ocular disorders. Glaukos Corporation, Knobbe Martens Olson & Bear, February 1, 2011: US07879001 (36 worldwide citation)

Intraocular implants and delivery instruments are disclosed for treating ophthalmic conditions and ocular disorders, such as glaucoma. The implants are configured to extend between the anterior chamber of the eye and a fluid outflow path or physiologic outflow pathway, such as Schlemm's canal, of th ...


3
David Steven Haffner, Gregory T Smedley, Hosheng Tu, Thomas W Burns: Devices and methods for glaucoma treatment. GLAUKOS CORPORATION, Knobbe Martens Olson & Bear, March 21, 2017: US09597230 (3 worldwide citation)

Intraocular implants and delivery instruments are disclosed for treating ophthalmic conditions and ocular disorders, such as glaucoma. The implants are configured to extend between the anterior chamber of the eye and a fluid outflow path or physiologic outflow pathway, such as Schlemm's canal, of th ...


4
Hosheng Tu, Barbara A Niksch, David S Haffner, Gregory T Smedley, Olav B Bergheim, Morteza Gharib, Richard A Hill, Thomas W Burns: Ocular implant with therapeutic agents and methods thereof. DOSE MEDICAL CORPORATION, Knobbe Martens Olson & Bear, October 17, 2017: US09789001

Implants and methods for treating ocular disorders are provided. One method involves introducing an implant into an anterior chamber of an eye. The implant is implanted into eye tissue adjacent the anterior chamber such that a proximal end of the implant resides in the anterior chamber following imp ...


5
Chee Hian Tan: Devices and methods for treatment of ocular disorders through delivery of therapeutic nucleic acids. DOHENY EYE INSTITUTE, Knobbe Martens Olson & Bear, November 6, 2018: US10117776

Several embodiments disclosed herein relate to the delivery of therapeutic nucleic acids to an ocular tissue in order to provide a therapeutic effect to reduce symptoms of or otherwise alleviate an ocular disorder. In particular embodiments, plasmid DNA is delivered to the cells of the trabecular me ...


6
DEVICES AND METHODS FOR TREATMENT OF OCULAR DISORDERS THROUGH DELIVERY OF THERAPEUTIC NUCLEIC ACIDS. May 4, 2017: US20170119580-A1

Several embodiments disclosed herein relate to the delivery of therapeutic nucleic acids to an ocular tissue in order to provide a therapeutic effect to reduce symptoms of or otherwise alleviate an ocular disorder. In particular embodiments, plasmid DNA is delivered to the cells of the trabecular me ...


7
DEVICES AND METHODS FOR TREATMENT OF OCULAR DISORDERS THROUGH DELIVERY OF THERAPEUTIC NUCLEIC ACIDS. March 21, 2019: US20190083312-A1

Several embodiments disclosed herein relate to the delivery of therapeutic nucleic acids to an ocular tissue in order to provide a therapeutic effect to reduce symptoms of or otherwise alleviate an ocular disorder. In particular embodiments, plasmid DNA is delivered to the cells of the trabecular me ...